COVID-19: New Drug ‘Reduces Hospitalisation, Deaths Of Patients By 85%’
Vir Biotechnology (Vir), a US company, and GlaxoSmithKline (GSK) have announced that their COVID-19 drug demonstrated a significant reduction in hospitalisation and death among patients during early treatment. The companies…
